Louis Kunkel, PhD
Director, Genomics Program, Boston Children’s Hospital; Professor of Genetics and Pediatrics, Harvard Medical School.
Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.
Alexander MS, Gasperini MJ, Tsai PT, Gibbs DE, Spinazzola JM, Marshall JL, Feyder MJ, Pletcher MT, Chekler EL, Morris CA, Sahin M, Harms JF, Schmidt CJ, Kleiman RJ, Kunkel LM.
Transl Psychiatry 2016;6(9):e901. PMCID: PMC5048211
Repression of phosphatidylinositol transfer protein alpha ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM, Spinazzola JM, Alexander MS, Moreira YB, Kawahara G, Gibbs DE, Mead LC, Verjovski-Almeida S, Zatz M, Kunkel LM.
Proc Natl Acad Sci U S A 2017;114(23):6080-5. PMCID: PMC5468635
Identification of a pathogenic mutation in ATP2A1 via in silico analysis of exome data for cryptic aberrant splice sites.
Bruels CC, Li C, Mendoza T, Khan J, Reddy HM, Estrella EA, Ghosh PS, Darras BT, Lidov HGW, Pacak CA, Kunkel LM, Modave F, Draper I, Kang PB.
Mol Genet Genomic Med 2019;7(3):e552. PMCID: PMC6418371